相关实验视频
Updated: Jul 17, 2025

10:43
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
3.4K
现实世界治疗模式和局部晚期食道状细胞癌的生存率
Hua-Chun Luo1, Jing-Jing Wu1, Li-Jun Zhu2,3
1Department of Tumor Integrated Therapy, The Fuzhou First General Hospital Affiliated with Fujian Medical University, Fuzhou, Fujian, China.
Medicine
|September 1, 2023
概括
这项研究表明,免疫疗法,并发化疗和二线或以上疗法显著改善局部晚期食道状细胞癌的存活率. 将免疫疗法添加到标准护理中可能会优化这些患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 临床医学 临床医学
- 癌症研究 癌症研究
背景情况:
- 对局部晚期食道状细胞癌 (LAESCC) 的现实治疗模式和临床疗效尚不清楚.
- 免疫疗法在LAESCC临床管理中的特定作用需要进一步阐明.
研究的目的:
- 调查现实世界的治疗环境和LAESCC.的临床结果.
- 分析免疫治疗对LAESCC患者整体存活 (OS) 和无进展存活 (PFS) 的影响.
主要方法:
- 从2010年1月至2019年12月期间诊断的363名LAESCC患者的临床数据的回顾性分析.
- 在接受免疫治疗和不接受免疫治疗的患者之间比较生存结果.
- 考克斯风险回归模型的应用,以确定预后因素.
主要成果:
- 同时进行化学放射治疗 (74.1%) 和帕克利塔塞尔/化学疗法 (14.3%) 是首要的第一线治疗方法.
- 甲/甲是主要的二线或以上 (≥2L) 治疗方案 (63.8%),其中25.3%接受免疫疗法.
- 免疫疗法,并发化疗和≥2L治疗是影响OS和PFS的显著独立因素.
结论:
- 同时化学放射治疗是LAESCC的标准治疗方法,对二线或以上疗法的意愿很高.
- 将免疫疗法纳入标准治疗方案显示出优化临床管理和改善LAESCC患者结果的潜力.
相关概念视频
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Esophageal Varices-II: Clinical Features and Management
94
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
94
Barrett Esophagus-II: Clinical Manifestations and Management
191
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
191
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Barrett Esophagus-I: Introduction
123
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
123

